Clinical Trial Update: Phase 1/2a Study of SQ3370 in Patients With Advanced Solid Tumors [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2a trial of SQ3370 in patients with advanced solid tumors has been terminated; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• SQ3370

Snippet

Sponsor: Shasqi, Inc. | Conditions: Cancer | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2025-11-14